Tara Barry

Centocor, Inc. manufactures healthcare products. Its products include avakine & reopro. The company was founded in 1979 by Hubert J. P. Schoemaker & Michael A. Wall and is headquartered in Horsham, PA.

ARC Medical Devices, Inc. develops and produces medical solution for the veterinary market worldwide. The company is headquartered in Richmond, Canada.

Harvard University engages in the provision of teaching and research. It has twelve degree-granting Schools in addition to the Radcliffe Institute for Advanced Study, offering a global education. The university was founded in 1636 and is headquartered in Cambridge, MA.

Part of The Goldman Sachs Group, Inc., Goldman Sachs Ltd. is an international merchant banking business. The company is based in London, UK. The CEOs of the British company are Philippe Louis Hubert Camu, Natasha Jhunjhunwala, Marie Lennon, Helen Moloney.

Agendia NV discovers and develops products for clinical management of cancer. It operates as a commercial-stage molecular diagnostic company that focuses on the discovery, development, and commercialization of products to improve the quality of life for cancer patients. The company was founded by Rene Bernards and Laura van't Veer in 2003 and is headquartered in Amsterdam, the Netherlands.

Norgine Pharmaceuticals Ltd. develops, manufactures and markets pharmaceutical products. Its products include destolit, klean-prep, movicol, movicol chocolate, movicol paediatric chocolate, normacol, setofilm 4mg/8mg, targxan 550mg, xerotin, xifaxanta 200mg and endocuff vision. The company was founded in 1906 and is headquartered in Middlesex, the United Kingdom.

HRA Pharma Development SARL develops medicines and products for women's health and endocrinology. It offers emergency contraception, uterine fibroids, regular contraception, intimate health, genital herpes, and Lysosafe service. The company was founded by André Ulmann in 1996 and is headquartered in Châtillon, France.

Azanta A/S develops pharmaceutical drugs for medical treatments in women´s health, oncology and addiction medicine. Its products include Angusta, which helps in cervical ripening and induction of labor. The firm also develops drugs for the treatment of head and neck cancer patients undergoing with radiotherapy. The company was founded by Claus Juan Møller-San Pedro and Jan Andersen in 1994 and is headquartered in Valby, Denmark.

Agendia, Inc. operates as a molecular diagnostics company. It develops and markets FFPE-based genomic diagnostic products, which help support physicians with their treatment decisions. Agendia?s tests can help physicians assess a patient?s individual risk for metastasis, it benefits from chemo, hormonal or combination therapy. The company was founded by Laura van't Veer and Ren? Bernards in 2003 and is headquartered in Irvine, CA.

Part of Norgine Europe BV, Merus Labs, Inc. is a Canadian pharmaceutical company that manufactures pharmaceutical products. The company is based in Vancouver, Canada. The company was founded by Penny White, Ahmad Doroudian. Paul William Pay has been the CEO of the company since 2017. Merus Labs was acquired by Range Gold Corp. on March 26, 2010.

LRQA Group Ltd. is a British company that provides type approval services to ensure that products conform to industry quality standards and international conventions. The company was founded in 1975 and is based in Solihull, UK. LRQA Group also has subsidiaries in France. In addition to type approval services, the company offers operational resilience and continuity of service to its clients, regardless of the outcome of Brexit.

Norgine Europe BV provides pharmaceutical products. It offers products for acute and chronic illnesses, including gastroenterology, hepatology, incontinence and pain management. The company was founded in 1906 and is headquartered in Amsterdam, the Netherlands.

Founded in 1906, Norgine is a specialty pharmaceutical company with an extensive pan-European presence. Throughout its long history, they have sought to develop and market high quality, innovative products for the benefit of both patients and physicians. They are committed to developing products not only to treat life-threatening conditions but, importantly, to improve the quality of life for patients with a range of acute and chronic illnesses. They have a long standing tradition of building relationships, based on the highest standards, with patients, physicians, employees, partners and other key stakeholders. In the last fifteen years, they have focused on expanding its pan-European infrastructure, and have moved to strengthen the Research & Development base of the company. In addition to developing, manufacturing and marketing its own pharmaceutical products, Norgine is an ideal partner for companies seeking assistance in the development and launch of innovative pharmaceutical products across Europe. They value its development partnerships as, together with its own in-house product development; they support its growth ambitions and will help to facilitate its continued business expansion. They have the resources to bring products to market on a pan-European or single country basis, combining sales and marketing expertise together with all development, clinical research, and product registration or manufacturing resources that its partners require. In the years ahead Norgine will continue to implement this successful strategy, building on its established infrastructure, strengthening its pan-European presence and collaborating with like-minded companies and organizations.

Norgine Ltd. provides pharmaceutical services. The company is headquartered in South Wales, the United Kingdom.

Norgine Pharma manufactures pharmaceutical product. It offers medicines, vaccines, tablets and injection. The company is headquartered in Dreux, France.

Part of Norgine Europe BV, Norgine GmbH develops and markets medicines and medical devices. The company is based in Wettenberg, Germany. The CEOs of the German company are Christopher William Bath, Kenneth Eric Scrimgeour, Kenneth MacRitchie.

SpePharm AG acquires, registers, and markets medical value medicines for the hospital sector. Its brands include Dantrium IV, Dantrium, Dantamacrin, Lymphoseek and Mugard. The company was founded in 2012 and is headquartered in Luzern, Switzerland.

Advania AB provides information technology (IT) services and solutions. It specializes in IT-outsourcing, contact center, IT-infrastructure and integration, and datacenter. The firm offers its products to public companies, and authorities. The company was founded in 2012 and is headquartered in Stockholm, Sweden.

Norgine Ventures Management Ltd. acts as an alternative investment manager. The company was founded by Peter Stein in 2012 and is headquartered in Harefield, the United Kingdom.

Arc Medical Design Ltd. manufactures and supplies medical, dental instruments. Its products are ENDOCUFF and Wide-Eye Polyptrap. The company was founded on October 7, 2008 and is headquartered in Leeds, the Unite Kingdom.

Northvolt AB manufactures lithium-ion batteries. Its properties include Foundry, Chemistry and Formfactor. The firm also provides solutions in the transportation, grid storage and industrial areas. The company was founded Peter Carlsson, Carl-Erik Lagercrantz, Olof Harald Mix and Paolo Cerruti in October 2016 and is headquartered in Stockholm, Sweden.

Exzell Pharma operates as a prescription pharmaceutical company. It offers Swiss Natural supplements, Myoflex, and Ozonol. The company was founded by Pardeep Nijhawan in 2014 and is headquartered in Markham, Canada.